NCT00270478View on ClinicalTrials.gov

Hydroxyurea and Erythropoietin to Treat Sickle Cell Anemia

PHASE1CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

December 21, 2005

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2009

Conditions
Sickle Cell DiseaseChronic Kidney DiseasePulmonary Hypertension
Interventions
DRUG

Erythropoietin and Hydroxyurea

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT00270478 - Hydroxyurea and Erythropoietin to Treat Sickle Cell Anemia | Biotech Hunter | Biotech Hunter